1-(2-fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)urea,
RSV 604,
RSV-604,
RSV604,
RSV604,
RSV-604,
676128-63-5,
A-60444,
UNII-6NF9HI6D98,
6NF9HI6D98,
1-(2-fluorophenyl)-3-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]urea,
1-(2-Fluorophenyl)-3-((3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)urea,
AC1NQUHO,
SCHEMBL641779,
CHEMBL223402,
RSV 604,
BCP19830,
EX-A1687,
ZINC3986763,
CS-4438,
HY-12993,
RSV604, >=98% (HPLC),
A-58175,
(S)-1-(2-fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea,
(S)-1-(2-Fluoro-phenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea,
(S)-N-(2-Fluorophenyl)-N'-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo(E)(1,4)diazepin-3-yl)urea,
Urea, N-((3S)-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(2-fluorophenyl)-,
RSV therapeutics, Arrow,
D09KNG,
RSV therapeutics, Novartis,
AIDS303540,
Antivirals (RSV), Arrow/ Virogen,
CID5279172,
A-60445,
Respiratory syncytial virus therapeutics, Novartis,
Respiratory syncytial virus therapeutics, Arrow/Virogen,